LU84662A1 - Nouvelles glycoproteines,procedes pour leur preparation et agents therapeutiques contenant ces glycoproteines en vue de combattre les tumeurs - Google Patents

Nouvelles glycoproteines,procedes pour leur preparation et agents therapeutiques contenant ces glycoproteines en vue de combattre les tumeurs Download PDF

Info

Publication number
LU84662A1
LU84662A1 LU84662A LU84662A LU84662A1 LU 84662 A1 LU84662 A1 LU 84662A1 LU 84662 A LU84662 A LU 84662A LU 84662 A LU84662 A LU 84662A LU 84662 A1 LU84662 A1 LU 84662A1
Authority
LU
Luxembourg
Prior art keywords
reaction
sulfuric acid
gives
color indicating
cells
Prior art date
Application number
LU84662A
Other languages
English (en)
French (fr)
Inventor
Haruo Ohnishi
Yasuo Suzuki
Ei Mochida
Kazuo Yamaguchi
Nobuo Mochida
Original Assignee
Mochida Pharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP57028993A external-priority patent/JPS58146293A/ja
Priority claimed from JP57028992A external-priority patent/JPS58148826A/ja
Priority claimed from JP57087674A external-priority patent/JPS58203917A/ja
Priority claimed from JP57087675A external-priority patent/JPS58203918A/ja
Priority claimed from JP57108046A external-priority patent/JPS58225024A/ja
Application filed by Mochida Pharm Co Ltd filed Critical Mochida Pharm Co Ltd
Publication of LU84662A1 publication Critical patent/LU84662A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y10S530/809—Fused cells, e.g. hybridoma
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/828—Cancer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
LU84662A 1982-02-26 1983-02-25 Nouvelles glycoproteines,procedes pour leur preparation et agents therapeutiques contenant ces glycoproteines en vue de combattre les tumeurs LU84662A1 (fr)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
JP2899382 1982-02-26
JP2899282 1982-02-26
JP57028993A JPS58146293A (ja) 1982-02-26 1982-02-26 抗腫瘍性糖蛋白質の製造方法
JP57028992A JPS58148826A (ja) 1982-02-26 1982-02-26 糖蛋白質および腫瘍治療剤
JP8767482 1982-05-24
JP57087674A JPS58203917A (ja) 1982-05-24 1982-05-24 糖蛋白質およびその製法ならびに腫瘍治療剤
JP8767582 1982-05-24
JP57087675A JPS58203918A (ja) 1982-05-24 1982-05-24 糖蛋白質およびその製造法ならびに腫瘍治療剤
JP10804682 1982-06-23
JP57108046A JPS58225024A (ja) 1982-06-23 1982-06-23 糖蛋白質およびその製造方法ならびに腫瘍治療剤

Publications (1)

Publication Number Publication Date
LU84662A1 true LU84662A1 (fr) 1983-09-08

Family

ID=27521092

Family Applications (1)

Application Number Title Priority Date Filing Date
LU84662A LU84662A1 (fr) 1982-02-26 1983-02-25 Nouvelles glycoproteines,procedes pour leur preparation et agents therapeutiques contenant ces glycoproteines en vue de combattre les tumeurs

Country Status (17)

Country Link
US (1) US4481137A (fi)
BE (1) BE896027A (fi)
BR (1) BR8300933A (fi)
DD (1) DD209634A5 (fi)
DE (1) DE3306297A1 (fi)
DK (1) DK93383A (fi)
FI (1) FI830638L (fi)
FR (1) FR2522267A1 (fi)
GB (1) GB2117385B (fi)
GR (1) GR78097B (fi)
LU (1) LU84662A1 (fi)
NL (1) NL8300727A (fi)
NO (1) NO830669L (fi)
PL (1) PL240784A1 (fi)
PT (1) PT76296B (fi)
RO (1) RO85901B (fi)
SE (1) SE8301073L (fi)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4920196A (en) * 1982-07-30 1990-04-24 Genentech, Inc. Human lymphotoxin
DE3334405A1 (de) * 1983-09-23 1985-04-04 Behringwerke Ag, 3550 Marburg Membranassoziierte proteine (mp(pfeil abwaerts)2(pfeil abwaerts)), verfahren zu ihrer gewinnung sowie ihre verwendung
JPS60112718A (ja) * 1983-11-21 1985-06-19 Kyorin Pharmaceut Co Ltd 抗腫瘍作用を示す蛋白性物質及びその製造方法
US4758549A (en) * 1983-12-13 1988-07-19 Kabushiki Kaisha Mayashibara Seibutsu Kagaku Kenkyujo Lymphokine, monoclonal antibody specific to the lymphokine and their production and uses
US4879226A (en) * 1984-04-06 1989-11-07 Asahi Kasei Kogyo Kabushiki Kaisha Novel human physiologically active polypeptide
US5683688A (en) 1984-05-31 1997-11-04 Genentech, Inc. Unglycosylated recombinant human lymphotoxin polypeptides and compositions
US4959457A (en) * 1984-05-31 1990-09-25 Genentech, Inc. Anti-lymphotoxin
US6686455B1 (en) 1984-07-05 2004-02-03 Genentech, Inc. Tumor necrosis factor
US5672347A (en) * 1984-07-05 1997-09-30 Genentech, Inc. Tumor necrosis factor antagonists and their use
FR2568125B1 (fr) * 1984-07-25 1988-04-15 Kogo Michiko Agent anti-tumeur contenant la proteine du sucre
US5019385A (en) * 1984-11-09 1991-05-28 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Novel lymphopine LK 2 and pharmaceutic compositions containing same
JPH0631318B2 (ja) * 1985-09-18 1994-04-27 株式会社林原生物化学研究所 新リンホカインｉｉｉとその製法
US4822605A (en) * 1986-02-18 1989-04-18 Exovir, Inc. Compositions and methods employing the same for the treatment of viral and cancerous skin lesions and the like
JPH03501620A (ja) * 1988-07-15 1991-04-11 ザ・トラステイーズ・オブ・コロンビア・ユニヴアーシテイ・イン・ザ・シテイ・オブ・ニユー・ヨーク 腫瘍壊死増強因子並びに製造及び使用の方法
US5106745A (en) * 1989-12-06 1992-04-21 Board Of Regents, The University Of Texas System Broad spectrum virus inhibitor, UTI-β
JP3552240B2 (ja) * 1993-02-23 2004-08-11 第一製薬株式会社 高濃度ｔｃｆ製剤
US5641867A (en) 1993-09-29 1997-06-24 The Trustees Of Columbia University In The City Of New York Antibody which specifically binds to endothelial-monocyte activating polypeptide II
JP4006058B2 (ja) * 1997-03-11 2007-11-14 第一三共株式会社 多臓器不全予防及び／又は治療剤
CA2253629A1 (en) * 1997-03-14 1998-09-24 Snow Brand Milk Products Co., Ltd. Agent for preventing and/or treating cachexia
BG65084B1 (bg) * 2002-03-13 2007-02-28 Закрьiтое Акционерное Общество, Производственное Предприятие"Эндо-Фарм-А" Нов клас биоактивни гликопротеини
US7341841B2 (en) * 2003-07-12 2008-03-11 Accelr8 Technology Corporation Rapid microbial detection and antimicrobial susceptibility testing
US20120077206A1 (en) 2003-07-12 2012-03-29 Accelr8 Technology Corporation Rapid Microbial Detection and Antimicrobial Susceptibility Testing
CA2956645A1 (en) 2003-07-12 2005-03-31 David A. Goldberg Sensitive and rapid biodetection
US10254204B2 (en) 2011-03-07 2019-04-09 Accelerate Diagnostics, Inc. Membrane-assisted purification
US9434937B2 (en) 2011-03-07 2016-09-06 Accelerate Diagnostics, Inc. Rapid cell purification systems
US9677109B2 (en) 2013-03-15 2017-06-13 Accelerate Diagnostics, Inc. Rapid determination of microbial growth and antimicrobial susceptibility
US10023895B2 (en) 2015-03-30 2018-07-17 Accelerate Diagnostics, Inc. Instrument and system for rapid microogranism identification and antimicrobial agent susceptibility testing
US10253355B2 (en) 2015-03-30 2019-04-09 Accelerate Diagnostics, Inc. Instrument and system for rapid microorganism identification and antimicrobial agent susceptibility testing

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2726886A1 (de) * 1977-06-15 1979-01-18 Behringwerke Ag Neues glykoprotein und verfahren zu dessen herstellung
JPS6030291B2 (ja) * 1978-03-20 1985-07-16 森永乳業株式会社 人顆粒球の分化増殖を促進するｈｇｉ糖蛋白質、ｈｇｉ糖蛋白質の製造法及びｈｇｉ糖蛋白質を含有する白血球減少症治療剤
US4261976A (en) * 1978-10-03 1981-04-14 The Massachusetts General Hospital Method and glycoprotein composition for inhibition of growth of transformed cells and tumors
US4243582A (en) * 1979-04-26 1981-01-06 Monsanto Company Novel glycoproteins from bovine cartilage

Also Published As

Publication number Publication date
SE8301073L (sv) 1983-08-27
NO830669L (no) 1983-08-29
BR8300933A (pt) 1983-11-16
GB2117385B (en) 1985-05-09
DD209634A5 (de) 1984-05-16
PT76296B (en) 1985-11-12
GB8305330D0 (en) 1983-03-30
PT76296A (en) 1983-03-01
RO85901B (ro) 1985-01-30
PL240784A1 (en) 1983-11-07
DK93383D0 (da) 1983-02-25
FI830638A0 (fi) 1983-02-25
FR2522267A1 (fr) 1983-09-02
DE3306297A1 (de) 1983-09-15
SE8301073D0 (sv) 1983-02-25
NL8300727A (nl) 1983-09-16
GB2117385A (en) 1983-10-12
BE896027A (fr) 1983-08-25
US4481137A (en) 1984-11-06
RO85901A (ro) 1985-01-24
FI830638L (fi) 1983-08-27
GR78097B (fi) 1984-09-26
DK93383A (da) 1983-08-27

Similar Documents

Publication Publication Date Title
LU84662A1 (fr) Nouvelles glycoproteines,procedes pour leur preparation et agents therapeutiques contenant ces glycoproteines en vue de combattre les tumeurs
DK169479B1 (da) Fremgangsmåde til fremstilling af humanspecifikt type II-interferon
CH637831A5 (fr) Procede de preparation d'interferon et preparation le contenant.
CH664974A5 (fr) Production du facteur de lyse des cellules-cibles.
JP2004307458A (ja) 抗癌、免疫及び造血機能増進効果と酸化的生体損傷の抑制効果を持った生薬組成物とその製造方法
Brent The effect of immune reactions on fetal development
CH664969A5 (fr) Lymphokine humain, sa production et son utilisation pour obtenir un anticorps monoclonal specifique de ce lymphokine.
Paronetto Immunologic factors in alcoholic liver disease
KR930004596B1 (ko) 신규 림포킨(lymphokine) 및 이에 대해 특이성을 갖는 모노클로날(monoclonal) 항체의 제조 방법
US5244662A (en) Medicinal extract from a mixture of phellodendron and defatted seed of croton, and method for it's manufacture
CN110538175A (zh) 穿心莲内酯在制备用于促进胆固醇逆转运的促进剂中的应用
FR2615737A1 (fr) Preparation et utilisation d'interferon-gamma
FR2634380A1 (fr) Regulateur biologique, actif dans diverses pathologies
FR2499409A1 (fr) Agent therapeutique a base d'une protease acide, pour le traitement des troubles allergiques, des maladies avec immunocomplexe et des tumeurs
BE873594A (fr) Interferon et preparation le contenant
FR2527630A1 (fr) Enzyme leucocytaire humaine de type pepsique, procede pour sa preparation et agent therapeutique la contenant
Molomut et al. A lymphocytopenic filterable agent derived from tissue cell cultures of murine carcinoma
CN110833550B (zh) 吡唑并嘧啶衍生物在治疗急性胰腺炎致肝损伤的用途
Gonciarz et al. Potential therapeutic role of melatonin in hepatobiliary diseases: current evidence and clinical observations.
IE910973A1 (en) Supportive use of Linomide (R)
FR2786103A1 (fr) Utilisation de trioxyde d'arsenic pour la preparation d'un medicament destine a traiter les affections neoplastiques du tissu hematopoietique chez un mammifere et nouvelle composition pharmaceutique
JPH0764744B2 (ja) 標的細胞障害性因子とヒトインタ−フェロンとを有効成分として含有する悪性腫瘍治療剤
JPS58225024A (ja) 糖蛋白質およびその製造方法ならびに腫瘍治療剤
RU2197265C1 (ru) Лекарственное средство и способ лечения нарушений функции гепатобилиарной системы
KR870001433B1 (ko) 적상적혈구(的狀赤血球) 붕괴인자의 제조 방법